News | Cardiac Rehabilitation | November 15, 2016

Study Finds Cardiovascular Rehab Helps Reduce Death Risk in Depressed Heart Patients

Data show four times higher death rate for moderately to severely depressed patients than those with no or mild depression, but rehab decreased death rate of first group 75 percent

cardiac rehabilitation, depression, death risk, heart surgery, Intermountain Medical Center Heart Institute, AHA Scientific Sessions 2016

November 15, 2016 — Depression has been known to be associated with poor cardiovascular outcomes. But if patients who are depressed attend cardiac rehabilitation after heart surgery, their risk of death is significantly reduced, according to a new study.

The study, conducted by researchers at Intermountain Medical Center Heart Institute in Salt Lake City, found that patients who were moderately to severely depressed had a higher risk of death after cardiovascular surgery than patients with mild to no depression. However, if those moderately to severely depressed patients attended rehabilitation after surgery, their risk of death was moderately reduced.

“We know the presence of moderate to severe depressive symptoms prior to cardiovascular surgery is a major risk factor for death, but our study shows that if those patients attend cardiac rehabilitation, their risk for death decreases significantly,” said the Intermountain Medical Center Heart Institute’s Viet Le, MPAS, PA, lead author of the study.

Results of the study were presented at the 2016 American Heart Association’s Scientific Session, Nov. 12-16 in New Orleans.

Le said several benefits of cardiac rehabilitation may play a role in reducing the risk for death in heart patients after cardiovascular surgery.

“We think cardiac rehab helps patients to manage their expectations as they return to work and life,” he said. “This comes from having a support group of fellow patients who may be further along in their rehab, as well as having exercise and activity protocols managed by experienced staff who can encourage consistent follow-up as well as ‘slow’ an overly enthusiastic patient. Getting patients out of their home after surgery, where they may overthink the effects of the disease, to a place where their job is to heal can enhance not only their physical recovery but their emotional health.”

The research indicates that patients who attend rehabilitation after surgery reduced their risk of death by nearly half, Le said, but further study is required to determine whether other factors contribute to this result, as well.

The Intermountain Medical Center Heart research team compiled information from 118 patients undergoing heart surgery who completed a nine-question patient health questionnaire (PHQ)-9 during an outpatient visit before their surgery.

Patients were categorized based on their results of their survey as having no to mild depressive symptoms or moderate to severe depressive symptoms. Following each patient’s completion of the last questionnaire, patients were followed post-surgery to determine the association of pre-surgery PHQ-9 depressive symptoms and death.

At the conclusion of the study, death occurred in 6.1 percent in patients with no to mild depressive symptoms and in about 25 percent of heart patients with moderate to severe depressive symptoms, showing that depressive symptoms were significantly associated with death.

Among patients with moderate to severe depression however, attending cardiac rehabilitation significantly decreased their risk of death by 74 percent (HR=0.26, p=0.02).

Other Intermountain Medical Center Heart Institute researchers involved in the study include: Tami L. Bair, Jose Benuzillo; Heidi T. May, Ph.D.; Kirk U. Knowlton, M.D.; Donald L. Lappé, M.D.; and Joseph B. Muhlestein, M.D.

Intermountain Medical Center is the flagship facility for the Intermountain Healthcare system, which is based in Salt Lake City.

For more information: www.scientificsessions.org

Related Content

The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device. 

The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device. 

News | Cardiac Diagnostics | July 29, 2021
July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation Ambula
The FDA has cleared Angel Medical Systems' second-generation AngelMed Guardian device. The implantable cardiac device detects and warns patients if they are having an acute coronary syndrome (ACS) event, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery that could potentially double the life of the implanted device

The FDA has cleared Angel Medical Systems' second-generation AngelMed Guardian device. The implantable cardiac device detects and warns patients if they are having an acute coronary syndrome (ACS) event, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery that could potentially double the life of the implanted device

News | Cardiac Diagnostics | July 01, 2021
July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc.
Ophthalmic optical coherence tomography (OCT) scan view of the macula in retina with vessels. Detecting heart disease with OCT imaging of the eye.Getty Images

Ophthalmic optical coherence tomography (OCT) scan view of the macula in retina with vessels. Getty Images
 

News | Cardiac Diagnostics | March 08, 2021
March 8, 2021 — In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a potent
Alivecor's pocket ECG system allows consumers or cardiologists to record a single lead ECG. AI algorithms can determine if their ECG is normal or abnormal and identify the arrhythmia.

Alivecor's pocket ECG system allows consumers or cardiologists to record a single lead ECG strip on a smartphone. AI algorithms can determine if their ECG is normal or abnormal and identify the arrhythmia. 

News | Cardiac Diagnostics | March 03, 2021
March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management s
A study of more than 100 million Americans in 3,123 counties found a correlation between cardiac death and their level of income. Getty Images Health disparities in cardiovascular disease.

A study of more than 100 million Americans in 3,123 counties found a correlation between cardiac death and their level of income. Getty Images

News | Cardiac Diagnostics | February 02, 2021
February 2, 2021 — A new study has found in the U.S.
A new study highlights the importance of continued public education regarding the risks of cigarette smoking and the failure of dual use with vaping to reduce cardiovascular risk. Getty Images

A new study highlights the importance of continued public education regarding the risks of cigarette smoking and the failure of dual use with vaping to reduce cardiovascular risk. Getty Images

News | Cardiac Diagnostics | January 06, 2021
January 6, 2021 — Smoking traditional cigarettes in addition to using e-cigarettes results in harmful health effects
The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia.

The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia. 

News | Cardiac Diagnostics | October 06, 2020
October 6, 2020 — A new technology being developed by U.S.-based Mesuron Inc.
With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. Amyloidosis Patient Registry  #Amyloidosis

With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. This is Figure 2, showing how SPECT imaging allows the reader to distinguish between blood pool activity (ventricular cavity, etc) and myocardial activity and identify regional myocardial differences in radiotracer uptake.

News | Cardiac Diagnostics | March 05, 2020
March 5, 2020 — More than 300 patients have joined the Amyloidosis Patient Registry and it is now available to the en